FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2579008299> ?p ?o ?g. }

• W2579008299 abstract "Abstract Despite recent progresses in treatment, invasive aspergillosis (IA) is still associated with high treatment failure and elevated death rates. Prognostic factors have not yet been identified in a large population of oncohematological patients (pts) developing IA. We reviewed all cases of possible, probable or definite IA according to the EORTC/MSG criteria occurring in adult oncohematological pts since January 1997. Two hundred and ninety nine pts received at least one dose of anti-aspergillus therapy and were analyzed for prognosis factors. Demographic, clinical, radiological, biological and mycological variables available at time of start of antifungal therapy were analyzed for their effects on 3-month specific survival (pts dying of another cause were censored at time of death) and 3-month overall survival. All variables with a p-value less than 0.2 in univariate analysis were introduced into a multivariate Cox regression model, allowing for interactions. The analysis was stratified by the type of first line therapy to produce a consistent analysis of the other variables. Underlying condition included allogeneic hematopoietic stem cell transplantation (HSCT) (n=41), autologous HSCT (n=24), solid organ transplantation (SOT) (n=10), acute leukemia (n=91), other hematological malignancy (n=67), solid tumor (n=35) or non-malignant disease (n=21). Infection was localized to the lung in 258 pts, to another single organ, mostly sinuses, in 12 pts and was disseminated in 19 cases. Overall and specific survival rates at 3 months were 52.3% (95% CI: 46.5–57.9%) and 59.5% (95% CI: 53.6–65.0%) respectively. Prognostic factors for 3-month overall survival are shown in table 1. Prognosis factors for 3-month specific survival were the same, with the following exceptions: monocyte count was no more significant (p=0.57), baseline neutrophil count (< vs. ≥ 500 μ L) and radiological aspects (single vs. multiple vs. diffuse lesions) became significant with p-values at 0.003 and 0.048 respectively. Our study identified several risk factors for death in oncohematological pts with IA. These factors should help to early identify pts who would benefit from more aggressive antifungal therapeutic strategies. Table 1. Three-month overall survival after stratification on treatment Predictor Reference category Hazard ratio 95% CI p-value Host factor AlloHSCT or SOT Hematological malignancy 1.78 1.12–2.84 0.0391 Other 1.52 0.86–2.68 Progression of underlying disease No 4.54 2.68–7.67 <0.001 Prior non-infectious respiratory disease Absence 1.76 1.18–2.62 0.006 Steroids dose ≥ 0.2 mg/kg <0.2 mg/kg 2.33 1.50–3.63 <0.001 Creatinine clearance 30–59 mL/min ≥ 60 mL/min 1.65 1.06–2.55 <0.001 <30 mL/min 2.51 1.56–4.03 Monocytes >100/μ L ≤ 100/μ L 0.59 0.41–0.85 0.004 Site of infection Disseminated Lung only 3.20 1.72–5.93 0.001 Other single organ NA NA Pleural effusion Absence 1.77 1.19–2.63 0.005 Possible IA Probable or definite 0.51 0.34–0.780.002" @default.
• W2579008299 created "2017-01-26" @default.
• W2579008299 creator A5015832963 @default.
• W2579008299 creator A5017660809 @default.
• W2579008299 creator A5028385850 @default.
• W2579008299 creator A5032939246 @default.
• W2579008299 creator A5035094985 @default.
• W2579008299 creator A5035371903 @default.
• W2579008299 creator A5041674125 @default.
• W2579008299 creator A5043753326 @default.
• W2579008299 creator A5044029525 @default.
• W2579008299 creator A5053134750 @default.
• W2579008299 creator A5060216130 @default.
• W2579008299 creator A5064131201 @default.
• W2579008299 date "2006-11-16" @default.
• W2579008299 modified "2023-10-09" @default.
• W2579008299 title "Prognostic Factors for Survival in Invasive Aspergillosis in Adult Oncohematological Patients." @default.
• W2579008299 doi "https://doi.org/10.1182/blood.v108.11.2852.2852" @default.
• W2579008299 hasPublicationYear "2006" @default.
• W2579008299 type Work @default.
• W2579008299 sameAs 2579008299 @default.
• W2579008299 citedByCount "1" @default.
• W2579008299 crossrefType "journal-article" @default.
• W2579008299 hasAuthorship W2579008299A5015832963 @default.
• W2579008299 hasAuthorship W2579008299A5017660809 @default.
• W2579008299 hasAuthorship W2579008299A5028385850 @default.
• W2579008299 hasAuthorship W2579008299A5032939246 @default.
• W2579008299 hasAuthorship W2579008299A5035094985 @default.
• W2579008299 hasAuthorship W2579008299A5035371903 @default.
• W2579008299 hasAuthorship W2579008299A5041674125 @default.
• W2579008299 hasAuthorship W2579008299A5043753326 @default.
• W2579008299 hasAuthorship W2579008299A5044029525 @default.
• W2579008299 hasAuthorship W2579008299A5053134750 @default.
• W2579008299 hasAuthorship W2579008299A5060216130 @default.
• W2579008299 hasAuthorship W2579008299A5064131201 @default.
• W2579008299 hasConcept C10515644 @default.
• W2579008299 hasConcept C126322002 @default.
• W2579008299 hasConcept C141071460 @default.
• W2579008299 hasConcept C143998085 @default.
• W2579008299 hasConcept C144301174 @default.
• W2579008299 hasConcept C203014093 @default.
• W2579008299 hasConcept C2776391196 @default.
• W2579008299 hasConcept C2777408962 @default.
• W2579008299 hasConcept C2779134260 @default.
• W2579008299 hasConcept C2779399171 @default.
• W2579008299 hasConcept C2908647359 @default.
• W2579008299 hasConcept C2911091166 @default.
• W2579008299 hasConcept C29374701 @default.
• W2579008299 hasConcept C38180746 @default.
• W2579008299 hasConcept C50382708 @default.
• W2579008299 hasConcept C71924100 @default.
• W2579008299 hasConcept C99454951 @default.
• W2579008299 hasConceptScore W2579008299C10515644 @default.
• W2579008299 hasConceptScore W2579008299C126322002 @default.
• W2579008299 hasConceptScore W2579008299C141071460 @default.
• W2579008299 hasConceptScore W2579008299C143998085 @default.
• W2579008299 hasConceptScore W2579008299C144301174 @default.
• W2579008299 hasConceptScore W2579008299C203014093 @default.
• W2579008299 hasConceptScore W2579008299C2776391196 @default.
• W2579008299 hasConceptScore W2579008299C2777408962 @default.
• W2579008299 hasConceptScore W2579008299C2779134260 @default.
• W2579008299 hasConceptScore W2579008299C2779399171 @default.
• W2579008299 hasConceptScore W2579008299C2908647359 @default.
• W2579008299 hasConceptScore W2579008299C2911091166 @default.
• W2579008299 hasConceptScore W2579008299C29374701 @default.
• W2579008299 hasConceptScore W2579008299C38180746 @default.
• W2579008299 hasConceptScore W2579008299C50382708 @default.
• W2579008299 hasConceptScore W2579008299C71924100 @default.
• W2579008299 hasConceptScore W2579008299C99454951 @default.
• W2579008299 hasLocation W25790082991 @default.
• W2579008299 hasOpenAccess W2579008299 @default.
• W2579008299 hasPrimaryLocation W25790082991 @default.
• W2579008299 hasRelatedWork W1998259048 @default.
• W2579008299 hasRelatedWork W2053375584 @default.
• W2579008299 hasRelatedWork W2139305524 @default.
• W2579008299 hasRelatedWork W2361700749 @default.
• W2579008299 hasRelatedWork W2383057318 @default.
• W2579008299 hasRelatedWork W2386134303 @default.
• W2579008299 hasRelatedWork W2388119532 @default.
• W2579008299 hasRelatedWork W2522557386 @default.
• W2579008299 hasRelatedWork W2996494612 @default.
• W2579008299 hasRelatedWork W3018143780 @default.
• W2579008299 isParatext "false" @default.
• W2579008299 isRetracted "false" @default.
• W2579008299 magId "2579008299" @default.
• W2579008299 workType "article" @default.